Try new Gibco Insulin-Transferrin-Selenium Select supplements, an animal-origin free formulation. Available in ITS-G & ITS-X. Learn more >
Geneticin™ selektives Antibiotikum (G418-Sulfat), Pulver
Das tatsächliche Produkt kann abweichen
Gibco™

Geneticin™ selektives Antibiotikum (G418-Sulfat), Pulver

Geneticin™ selektives Antibiotikum (G418 Sulfat) wird erzeugt durch das Bakterium Micromonospora rhodorangea und wirkt durch Ribosombindung, wodurch die Proteinsynthese sowohlWeitere Informationen
Have Questions?
Ansicht ändernbuttonViewtableView
KatalognummerMenge
1181109825 g
118110231 g
118110315 g
Katalognummer 11811098
Preis (EUR)
2.375,00
Each
Menge:
25 g
Preis (EUR)
2.375,00
Each
Geneticin™ selektives Antibiotikum (G418 Sulfat) wird erzeugt durch das Bakterium Micromonospora rhodorangea und wirkt durch Ribosombindung, wodurch die Proteinsynthese sowohl in prokaryotischen als auch eukaryotischen Zellen gehemmt wird. Resistenz gegen Geneticin™ selektives Antibiotikum (G418 Sulfat) basiert auf Resistenzgenen von E. coli APH (3’) – I und APH (3’) – II. Gibco™ Geneticin™ selektives Antibiotikum (G418 Sulfat) dient als selektives Antibiotikum im Konzentrationsbereich von 100 bis 200 µg/ml bei Bakterien und 200 bis 500 µg/ml bei den meisten Säugetierzellen. Dieses Produkt wird als Pulver geliefert und sollte in einer Stammlösung von 10 bis 50 mg/ml in Wasser hergestellt werden. Wir bieten eine Vielzahl von Zellkultur-Antibiotika für Ihren Komfort.

Produktverwendung
Nur für Forschungszwecke: Nicht für diagnostische oder therapeutische Zwecke bei Tieren und Menschen vorgesehen.

cGMP-konformes Fertigungs- und Qualitätssystem an zwei Standorten
Zur Sicherung der Lieferkette stellen wir Gibco™ Geneticin™ Selektives Antibiotikum (G418-Sulfat) an zwei gesonderten Standorten in Grand Island, NY (USA) und Schottland (Großbritannien) her. Beide Standorte erfüllen die cGMP-Fertigungsanforderungen und sind ISO 13485-zertifiziert und bei der FDA als Hersteller medizinischer Geräte registriert.
Nur für Forschungszwecke: Nicht für diagnostische oder therapeutische Zwecke an Tieren und Menschen geeignet.
Specifications
ZelltypEukaryotische Zellen, prokaryotische Zellen
Konzentration10 bis 50 μg/ml
KulturtypSäugetierzellkultur, Insektenzellkultur
Zur Verwendung mit (Anwendung)Eukaryotische Auswahl⁄Erzeugung stabiler Zelllinien
ProduktlinieGeneticin
Menge25 g
Haltbarkeit24 Monate
VersandbedingungRaumtemperatur
FormPulver
ProdukttypAntibiotikum
SterilitätSteril
Unit SizeEach
Inhalt und Lagerung
Lagerbedingungen: 15 bis 30 °C
Versandbedingungen: Haltbarkeit bei
Umgebungstemperatur: 24 Monate ab Herstellungsdatum

Häufig gestellte Fragen (FAQ)

Which of your antibiotics (Geneticin, Zeocin, Hygromycin B, Blasticidin, and Puromycin) can be used together for stable selection in mammalian cells?

All of our antibiotics (Geneticin, Zeocin, Hygromycin B, Blasticidin, and Puromycin) can be used together for making multiple stable cell lines. However, kill curves will need to be performed for each combination of antibiotics since sensitivity to a given antibiotic tends to increase when combined with other antibiotics.

Can Neomycin be used in mammalian selection?  Can Neomycin be used instead of Kanamycin in bacterial selection?

No, Neomycin is toxic to mammalian cells. It also causes irreversible damage to kidneys and other organs. Geneticin (aka G418 Sulfate) is a less toxic and very effective alternative for selection in mammalian cells.  Neomycin can be used in bacterial selection, but Kanamycin is the preferred drug to use because of Neomycin's toxicity.

What are the recommended concentrations of antibiotics to use for selection in prokaryotes and eukaryotes?

For best results, optimal concentrations for selection should be determined empirically in each unique experiment through dose response curves. However, to get a general idea of concentrations that have worked for individual cell types, please click on the following url: http://www.thermofisher.com/us/en/home/life-science/cell-culture/transfection/selection.html or type in “Selection Antibiotics” into our main search on www.thermofisher.com.

In contrast to Geneticin (G418)-induced cell death, cells treated with Zeocin do not always detach and float when they die. Is this typical?

It is true that a percentage of non-resistant mammalian cells do not round-up from the plate upon Zeocin selection as would be seen with G418 or Hygromycin selection. However, one should see some very characteristic morphological changes occurring in those cells that are not resistant. These cells that stick to the culture dish typically display a vast increase in size. This could be best described as being similar to the effects of cytomegalovirus infecting permissive cells. The shape of these cells may also change; taking on an "alien" shape. On close examination of the non-resistant cells, the researcher should observe a distinct breakdown of both the nuclear and plasma membranes. Even though the "cells" are still attached to the plate, they should have the appearance of many holes in these membranes. Also, before the breakdown of the membranes, one can observe open areas in the cytoplasm of the cells that appear to be large, empty vesicles. Although not confirmed, this may be explained by a breakdown of the endoplasmic reticulum and Golgi apparatus, or other scaffolding proteins. Eventually, these "cells" will completely breakdown so that only "strings" of protein are left.

In contrast, Zeocin resistant cells should continue to divide at a regular interval to form distinct clumps of cells, or colonies. There should not be a distinct change in morphology, which can be compared to cells not under selection with Zeocin. It is these colonies of actively dividing cells that contain the resistance gene and are expressing it actively.

If there is concern about the dead cells sticking to the plate, one may do the following to eliminate them: Treat the plate for a couple of minutes with trypsin/versene. Both the healthy resistant cells and the dead cells will dislodge from the plate. The cells can then be replated (without Zeocin selection) and the healthy cells will attach again while the dead ones will not. After a couple of hours when the healthy cells have attached to the substrate again, Zeocin can be added back to the medium.

What is the mode of action on the following antibiotics: Blasticidin, Geneticin (G418), Hygromycin, and Zeocin?

Blasticidin: Nucleoside Inhibits protein synthesis in prokaryotic and eukaryotic cells by interfering with peptidyl transfer reaction of protein synthesis, causing early termination of translation.

Geneticin (G418): Aminoglycoside Blocks protein synthesis in mammalian cells by interfering with ribosomal function.

Hygromycin: Aminocyclitol Inhibits protein synthesis by disrupting translocation and promoting mistranslation.

Zeocin: Intercalates with DNA and cleaves it.

Zitierungen und Referenzen (13)

Zitierungen und Referenzen
Abstract
Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells.
Authors:Endo T; Ohta K; Haraguchi K; Onaya T;
Journal:J Biol Chem
PubMed ID:7738021
Thyrotropin receptor (TSH-R) has been thought to be thyroid-specific, but, by Northern blot analysis, we found that rat adipose tissue expressed TSH-R mRNAs in amounts approaching those in the thyroid. To investigate the function of TSH-R from adipose tissue, we screened a rat fat cell lambda gt11 cDNA library for ... More
Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin.
Authors: Setiadi H; Disdier M; Green S A; Canfield W M; McEver R P;
Journal:J Biol Chem
PubMed ID:7592923
'The cytoplasmic domains of many membrane proteins have short sequences, usually including a tyrosine or a di-leucine, that function as sorting signals. P-selectin is an adhesion receptor for leukocytes that is expressed on activated platelets and endothelial cells. Its 35-residue cytoplasmic domain contains signals for sorting into regulated secretory granules, ... More
Structural basis of G protein specificity of human endothelin receptors. A study with endothelinA/B chimeras.
Authors: Takagi Y; Ninomiya H; Sakamoto A; Miwa S; Masaki T;
Journal:J Biol Chem
PubMed ID:7730310
'The endothelin (ET) family of peptides acts via two subtypes of guanine nucleotide-binding regulatory protein (G protein)-coupled receptors termed ETA and ETB. ET-1 stimulated cAMP formation in Chinese hamster ovary (CHO) cells stably expressing human wild-type ETA (CHO/hETA cells) while it inhibited cAMP formation in CHO cells expressing human wild-type ... More
A region of human CD14 required for lipopolysaccharide binding.
Authors: Viriyakosol S; Kirkland T N;
Journal:J Biol Chem
PubMed ID:7529231
'CD14, a glycosylphosphatidylinositol-anchored protein on the surface of monocytes, macrophages, and polymorphonuclear leukocytes, is a receptor for lipopolysaccharide (LPS). CD14 binding of LPS is enhanced by serum proteins, especially lipopolysaccharide binding protein. The serum-dependent binding of LPS to CD14 stimulates macrophages to make cytokines, which can cause septic shock in ... More
Mechanisms of desensitization and resensitization of proteinase-activated receptor-2.
Authors: Böhm S K; Khitin L M; Grady E F; Aponte G; Payan D G; Bunnett N W;
Journal:J Biol Chem
PubMed ID:8703006
'Proteinase-activated receptor-2 (PAR-2) is a G-protein-coupled receptor that is expressed by intestinal epithelial cells, which are episodically exposed to pancreatic trypsin in the intestinal lumen. Trypsin cleaves PAR-2 to expose a tethered ligand, which irreversibly activates the receptor. Thus, PAR-2 may desensitize and resensitize by novel mechanisms. We examined these ... More